1 |
|
Ability of synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa to afford protection against P. aeruginosa infection in a murine acute pneumonia model
|
Hughes, E. E
|
Butterworths
|
1995
|
|
|
2 |
|
Absence of protein 2C from clarified foot-and-mouth disease virus vaccines provides the basis for distinguishing convalescent from vaccinated animals
|
Lubroth, J
|
Butterworths
|
1996
|
|
|
3 |
|
Acceptability of tetanus toxoid vaccine by pregnant women in two health centres in Abidjan (Ivory Coast)/
|
Ymba, A
|
Butterworths
|
2003
|
|
|
4 |
|
Acellular pertussis vaccine in children with perinatal human immunodeficiency virus-type 1 infection
|
De Martino, M
|
Butterworths
|
1997
|
|
|
5 |
|
Acellular pertussis vaccines containing genetically detoxified pertussistoxin induce long-lasting humoral and cellular responses in adults
|
Di Tommaso, A
|
Butterworths
|
1997
|
|
|
6 |
|
Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate for use in protein-polysaccharide conjugate vaccines and immunological reagents
|
Lees, A
|
Butterworths
|
1997
|
|
|
7 |
|
Activation patterns of murine B cells after oral administration of an encapsulated soluble antigen
|
Jain, S. L
|
Butterworths
|
1996
|
|
|
8 |
|
Acute effects of smoking cessation on antioxidant status
|
Brown, A. J
|
Butterworths
|
1980
|
|
|
9 |
|
Adamantylamide dipeptide as effective immunoadjuvant in rabbits and mice/
|
Becker, Pablo D
|
Butterworths
|
2001
|
|
|
10 |
|
Addition of lutein, lycopene, or �carotene to LDL or serum in vitro: Effects on carotenoid distribution, LDL composition, and LDL oxidation
|
Romanchik, J. E
|
Butterworths
|
1980
|
|
|
11 |
|
Addition of the MSA1 signal and anchor sequences to the malaria merozoite surface antigen 1 C-terminal region enhances immunogenicity when expressed by recombinant vaccinia virus
|
Torres-Duarte, A. P. Carroll, M. W. Yang, S. Moss, B.
|
Butterworths
|
1997
|
|
|
12 |
|
Addressing the weakest link: Implementing converged security
|
Aleem, A.; Wakefield, A.; Button, M.
|
Butterworths
|
2013
|
|
|
13 |
|
Adjuvancy and reactogenicity of N-acetylglucosaminyl-N-acetylmuramyl-dipeptide (GMDP) orally administered just prior to trivalent influenza subunit vaccine. A double-blind placebo-controlled study in nursing home residents
|
Palache, A. M
|
Butterworths
|
1996
|
|
|
14 |
|
Adjuvant activity of iscoms; effect of ratio and co-incorporation of antigen and adjuvant
|
Bengtsson, K. L
|
Butterworths
|
1996
|
|
|
15 |
|
Adjuvant activity of muramyl dipeptide derivatives to enhance immunogenicity of a hantavirus-inactivated vaccine
|
Yung Choon Yoo
|
Butterworths
|
1998
|
|
|
16 |
|
Adjuvant/carrier activity of inactivated tick-borne encephalitis virus
|
Leibl, H
|
Butterworths
|
1998
|
|
|
17 |
|
Adjuvant effect of biodegradable poly(DL-lactic acid) granules capable for antigen release following intraperitoneal injection
|
Tabata, Y. Nakaoka, R. Ikada, Y.
|
Butterworths
|
1996
|
|
|
18 |
|
Adjuvant properties of non-phospholipid liposomes (Novasomes[R]) in experimental animals for human vaccine antigens
|
Gupta, R. K
|
Butterworths
|
1997
|
|
|
19 |
|
Adjuvants - a classification and review of their modes of
|
Cox, J. C
|
Butterworths
|
1997
|
|
|
20 |
|
Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine
|
Neuzil, K. M
|
Butterworths
|
1997
|
|
|